These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 22250646

  • 1. Endothelin-1 and endothelin a receptor immunoreactivity is increased in patients with diabetic nephropathy.
    Zanatta CM, Veronese FV, Loreto Mda S, Sortica DA, Carpio VN, Eldeweiss MI, da Silva VD, Lopes TG, Gross JL, Canani LH.
    Ren Fail; 2012; 34(3):308-15. PubMed ID: 22250646
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G, Suzuki D, Toyoda M, Umezono T, Sakai H.
    Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of the compound of traditional Chinese drugs on gene expression of renal endothelin and its receptor of experimental diabetic nephropathy].
    Wan YG, Wan M, Fan Y, Gu LB, Li M.
    Zhongguo Zhong Yao Za Zhi; 2003 Feb; 28(2):159-62. PubMed ID: 15015294
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K, Zeier M, Gross ML, Waldherr R, Ritz E, Amann K.
    Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
    [Abstract] [Full Text] [Related]

  • 10. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B, Hugo CP, Hausknecht B, Boehmer KP, Riess RH, Schmieder RE.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy.
    Wu CC, Chen JS, Lu KC, Chen CC, Lin SH, Chu P, Sytwu HK, Lin YF.
    Clin Chim Acta; 2010 May 02; 411(9-10):700-4. PubMed ID: 20138168
    [Abstract] [Full Text] [Related]

  • 13. Collagen type VIII expression in human diabetic nephropathy.
    Gerth J, Cohen CD, Hopfer U, Lindenmeyer MT, Sommer M, Gröne HJ, Wolf G.
    Eur J Clin Invest; 2007 Oct 02; 37(10):767-73. PubMed ID: 17888087
    [Abstract] [Full Text] [Related]

  • 14. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
    Prakash J, Lodha M, Singh SK, Vohra R, Raja R, Usha.
    J Assoc Physicians India; 2007 Jun 02; 55():412-6. PubMed ID: 17879494
    [Abstract] [Full Text] [Related]

  • 15. Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease.
    Lin YL, Peng SJ, Ferng SH, Tzen CY, Yang CS.
    Int J Clin Pract; 2009 Aug 02; 63(8):1167-76. PubMed ID: 18422591
    [Abstract] [Full Text] [Related]

  • 16. Elevated epsilon-(gamma-glutamyl)lysine in human diabetic nephropathy results from increased expression and cellular release of tissue transglutaminase.
    El Nahas AM, Abo-Zenah H, Skill NJ, Bex S, Wild G, Griffin M, Johnson TS.
    Nephron Clin Pract; 2004 Aug 02; 97(3):c108-17. PubMed ID: 15292688
    [Abstract] [Full Text] [Related]

  • 17. Increased expression of selectins in kidneys of patients with diabetic nephropathy.
    Hirata K, Shikata K, Matsuda M, Akiyama K, Sugimoto H, Kushiro M, Makino H.
    Diabetologia; 1998 Feb 02; 41(2):185-92. PubMed ID: 9498652
    [Abstract] [Full Text] [Related]

  • 18. [Renal histological lesions in patients with type II diabetes mellitus].
    Castellano I, Covarsí A, Novillo R, Gómez-Martino JR, Ferrando L.
    Nefrologia; 2002 Feb 02; 22(2):162-9. PubMed ID: 12085417
    [Abstract] [Full Text] [Related]

  • 19. Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy.
    Zheng M, Lv LL, Cao YH, Zhang JD, Wu M, Ma KL, Phillips AO, Liu BC.
    Clin Endocrinol (Oxf); 2012 May 02; 76(5):657-64. PubMed ID: 21824169
    [Abstract] [Full Text] [Related]

  • 20. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ.
    Am J Kidney Dis; 2012 Jan 02; 59(1):75-83. PubMed ID: 22051245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.